Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Iranian Journal of Radiation Research. 2004; 1 (4): 229-31
in English | IMEMR | ID: emr-66127

ABSTRACT

Leiomyosarcoma is a rare entity in prostate but it is the most common type of prostate sarcomas in adult patients. In most reported series the prognosis is poor and the median survival is about 15-18 months. Hereby we present a 72 years old man who received combined modality treatment including radical surgery followed by adjuvant chemotherapy and radiotherapy. He has been well for 14 months, but now he is suffering from lung metastases and asymptomatic local recurrence


Subject(s)
Humans , Male , Leiomyosarcoma/diagnosis , Leiomyosarcoma/therapy , Radiotherapy, Adjuvant , Antineoplastic Agents , Chemotherapy, Adjuvant
SELECTION OF CITATIONS
SEARCH DETAIL